Leveraging Innovative Strategies for Speedy Cell Line Development

Cell line development (CLD) involves the derivation of clones from single cells. Thousands of these clones are then screened to identify those that are stable, produce high yields of bioproducts and exhibit the desired critical quality attributes (CQAs). Any misstep during this critically important phase can jeopardize or delay the path to product commercialization.

Gain insights into how the incorporation of innovative tools and technologies such as automated systems and high-throughput analytical screening tools can eliminate bottlenecks in clone selection, fast-track development timelines and reduce the cost per experiment.

Join this roundtable of industry experts as they discuss technologies, best practices and strategies for delivering robust, stable, high-yielding cell lines to accelerate and streamline the drug discovery process.

Key learnings:

• Understand the importance of identifying high performing cell lines early in the development process

• Explore analytical tools and techniques to optimize cell line development and selection workflows

• Discover a toolbox for accelerating your path to commercialization while minimizing risk.

Presenters:

• Raja Srinivas, PhD, Co-Founder, Asimov
• Susan Sharfstein, PhD, Professor of Nanobioscience in the College of Nanoscale Science and Engineering, SUNY Polytechnic Institute
• Saurabh Sen, PhD, Associate Director, Cell Line Development, Genomic Medicine Unit CMC, Sanofi

Register Here